OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - AMGEN | Market Closed - Deutsche Boerse AG 20:35:51 31/05/2024 BST | ||
| 0.59 EUR | -3.28% |
|
| Current month | -32.95% | ||
| 1 month | -32.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 0.59 | -3.28% |
| 30/05/24 | 0.61 | -7.58% |
| 29/05/24 | 0.66 | +6.45% |
| 28/05/24 | 0.62 | +12.73% |
| 27/05/24 | 0.55 | -3.51% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 08:35 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ34DQ |
| ISIN | DE000SQ34DQ2 |
| Date issued | 09/11/2022 |
| Strike | 368 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.97 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.48 € |
|---|---|
| Lowest since issue | 0.4 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
